CDK4/6 Inhibitor Plus Camrelizumab for PD-1 Inhibitor Refractory R/M NPC

Clinical trial NCT05724355 · UNKNOWN

Trial details

NCT number: NCT05724355
Sponsor: Sun Yat-sen University
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Nasopharyngeal Carcinoma

Start date: 2022-09-01
Primary completion: 2023-10-01
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.